Toward an 'off the shelf' technology for burn victims: Healing wounds with mesenchymal stem cells

Regenerative Medicine

Volumn 10, Issue 4, 2015, Pages 381-384

  Shabbir, Arsalan ^a   Badiavas, Evangelos V ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

adipose tissue; burns; homing; inflammation; mesenchymal stem cells; scarring; wound healing

Indexed keywords

ADIPOSE DERIVED STEM CELL; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOGENIC BONE MARROW TRANSPLANTATION; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BURN; BURN PATIENT; CELL ACTIVITY; CELL AGING; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL REGENERATION; DERMATITIS; ENGRAFTMENT; EXTRACELLULAR MATRIX; HUMAN; IMMUNOMODULATION; MACROPHAGE FUNCTION; MEDICAL TECHNOLOGY; MESENCHYMAL STEM CELL TRANSPLANTATION; MULTIPOTENT STEM CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SCAR FORMATION; THERAPY EFFECT; TREATMENT RESPONSE; WOUND HEALING; BURNS; CLINICAL TRIAL (TOPIC); CYTOLOGY; IMMUNOSUPPRESSIVE TREATMENT; MESENCHYMAL STROMA CELL; PATHOLOGY;

BURNS; CLINICAL TRIALS AS TOPIC; HUMANS; IMMUNOSUPPRESSION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; WOUND HEALING;

EID: 84930316822     PISSN: 17460751     EISSN: 1746076X     Source Type: Journal    
DOI: 10.2217/rme.15.20     Document Type: Review

References (19)

1. Castagnoli C, Trombotto C, Ondei S et al. Characterization of t-cell subsets infiltrating post-burn hypertrophic scar tissues. Burns 23 (7-8), 565-572 (1997).
2. Schwacha MG. Macrophages and post-burn immune dysfunction. Burns 29 (1), 1-14 (2003).
3. Ono I, Gunji H, Zhang JZ, Maruyama K, Kaneko F. A study of cytokines in burn blister fluid related to wound healing. Burns 21 (5), 352-355 (1995).
4. Mankikar SD. Stem cells: a new paradigm in medical therapeutics. J. Long Term Eff. Med. Implants 20 (3), 219-250 (2010).
5. Aga M, Bentz GL, Raffa S et al. Exosomal hif1alpha supports invasive potential of nasopharyngeal carcinoma-associated lmp1-positive exosomes. Oncogene 33 (37), 4613-4622 (2014).
6. Tanna T, Sachan V. Mesenchymal stem cells: potential in treatment of neurodegenerative diseases. Curr. Stem Cell Res. Ther. 9 (6), 513-521 (2014).
7. Prockop DJ. Repair of tissues by adult stem/progenitor cells (mscs): controversies, myths, and changing paradigms. Mol. Ther. 17 (6), 939-946 (2009).
8. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat. Rev. Immunol. 8 (9), 726-736 (2008).
9. Barbash IM, Chouraqui P, Baron J et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 108 (7), 863-868 (2003).
10. National Institute of Health database. www.clinicaltrials.gov
11. Lalu MM, Mcintyre L, Pugliese C et al. Safety of cell therapy with mesenchymal stromal cells (safecell): a systematic review and meta-analysis of clinical trials. PLoS ONE 7 (10), e47559 (2012).
12. Hare JM, Fishman JE, Gerstenblith G et al. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the poseidon randomized trial. JAMA 308 (22), 2369-2379 (2012).
13. Badiavas EV, Falanga V. Treatment of chronic wounds with bone marrow-derived cells. Arch. Dermatol. 139 (4), 510-516 (2003).
14. Shumakov VI, Onishchenko NA, Rasulov MF, Krasheninnikov ME, Zaidenov VA. Mesenchymal bone marrow stem cells more effectively stimulate regeneration of deep burn wounds than embryonic fibroblasts. Bull. Exp. Biol. Med. 136 (2), 192-195 (2003).
15. Yagi H, Soto-Gutierrez A, Kitagawa Y, Tilles AW, Tompkins RG, Yarmush ML. Bone marrow mesenchymal stromal cells attenuate organ injury induced by lps and burn. Cell Transplant. 19 (6), 823-830 (2010).
16. Bey E, Prat M, Duhamel P et al. Emerging therapy for improving wound repair of severe radiation burns using local bone marrow-derived stem cell administrations. Wound Repair Regen. 18 (1), 50-58 (2010).
17. Dominici M, Le Blanc K, Mueller I et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 8 (4), 315-317 (2006).
18. Bornes TD, Adesida AB, Jomha NM. Mesenchymal stem cells in the treatment of traumatic articular cartilage defects: a comprehensive review. Arthritis Res. Ther. 16 (5), 432 (2014).
19. Strioga M, Viswanathan S, Darinskas A, Slaby O, Michalek J. Same or not the same? Comparison of adipose tissuederived versus bone marrow-derived mesenchymal stem and stromal cells. Stem Cells Dev. 21 (14), 2724-2752 (2012).